Dr Nicholas Crombie and Professor Gavin Perkins discuss their randomised phase 3 trial in which they investigated resuscitation with blood products compared with saline in patients with trauma-related haemorrhagic shock receiving prehospital care. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.co ... Show More
Oct 29
Erdheim-Chester disease: a new international cohort study on phenotype, treatment, and determinants of prognosis
Professor Julien Haroche and Professor Augusto Vaglio join us this month to discuss their new international cohort study describing phenotype, treatment, and determinants of prognosis in 1174 patients with Erdheim-Chester disease. Click here to read the full article: https://www. ... Show More
13m 48s
Oct 6
Thalassaemia revisited: from health burden to breakthroughs
Thalassaemia care is advancing fast, from gene therapies to AI diagnostics, but access and prevention still lag behind. Hear from the authors of The Lancet Haematology's "Thalassaemia revisited: from health burden to breakthroughs" Series, produced with The Lancet Regional Health ... Show More
48m 17s
Aug 27
Adverse event reporting in haematological malignancies with the authors of our Adverse Events Series
Blood cancer treatments are advancing fast — but so are their side effects. Hear from the authors of The Lancet Haematology's Adverse Event reporting series on better trial design, patient-centric care, and what part 2 (2026) reveals about long-term toxicity, survivorship, regula ... Show More
35m 32s
Jun 2023
Fluid Therapy for Critically Ill Adults With Sepsis
<p>JAMA Senior Editor Kristin Walter, MD, MS, speaks with Fernando Zampieri, MD, PhD, assistant professor in the Department of Critical Care Medicine at the University of Alberta in Alberta, Canada, about fluid therapy in critically ill adults with sepsis.<br /> <br /> <strong>Re ... Show More
19m 50s
Sep 2021
Managing Fluids in Critically Ill Patients
Critically ill patients often require IV fluids for resuscitation but questions remain about the optimal type of IV fluid and best rate of IV fluid bolus infusion. JAMA Associate Editor Kristin Walter, MD, MS, discusses a recent clinical trial that examined the effect of 2 differ ... Show More
21m 6s